Skip Navigation LinksHome   |   Reference Center   |   Publication List
  • Print
  • Share

CIBMTR Publication List

Since 1972, use of CIBMTR data and statistical resources have resulted in more than 1,000 publications. These publications are organized by year below, and can be searched to help you quickly find the information you need. 

Display:



2017

Year Title Authors Publication
2017 A multicenter trial of myeloablative clofarabine and busulfan conditioning for relapsed or primary induction failure AML not in remission at the time of allogeneic hematopoietic stem cell transplantation. Magenau J, Westervelt P, Khaled S, McGuirk J, Hari P, Eapen M, Becker PS, Parkin B, Braun T, Logan B, Wang H, Jagasia M, Rowley SD, Kim DD, Schechter T, Frey N, Scott B, Churay T, Lieland S, Forman S, Mineishi S Bone Marrow Transplant 52(1):59-65
2017 Reduced Intensity Conditioned Allograft Yields Favorable Survival for Older Adults with B-cell Acute Lymphoblastic Leukemia: a CIBMTR Analysis. Rosko A, Wang H-L, de Lima M, Sandmaier B, Khoury HJ, Artz A, Brammer J, Bredeson C, Farag S, Kharfan-Dabaja MA, Lazarus HM, Marks DI, Martino Bufarull R, McGuirk J, Mohty M, Nishihori T, Nivison-Smith I, Rashidi A, Ringden O, Seftel M, Weisdorf D, Bachanova V, Saber W Am J Hematol 92(1):42-49
2017 National Institutes of Health Hematopoietic Cell Transplantation Late Effects Initiative: Consensus recommendations for research methodology and study design. Shaw BE, Hahn T, Martin PJ, Mitchell S, Petersdorf EW, Armstrong GT, Shelburne N, Storer B, Bhatia S Biol Blood Marrow Transplant 23(1):10-23
2017 Allogeneic transplantation for relapsed Waldenström macroglobulinemia and lymphoplasmacytic lymphoma. Cornell RF, Bachanova V, D'Souza A, Woo-Ahn K, Martens M, Huang J, Al-Homsi AS, Chhabra S, Copelan E, Diaz M-A, Freytes CO, Gale RP, Ganguly S, Hamadani M, Hildebrandt G, Kamble RT, Kharfan-Dabaja MA, Kindwall-Keller TL, Lazarus HM, Marks DI, Nishihori T, Olsson RF, Saad A, Usmani S, Vesole D, Yared J, Mark T, Nieto Y, Hari P Biol Blood Marrow Transplant 23(1):60-66
2017 Recipient HLA-C haplotypes and miRNA 148a/b binding sites have no impact on allogeneic hematopoietic cell transplantation outcomes. Hoff GA, Fischer JC, Hsu K, Cooley S, Miller JS, Wang T, Haagenson M, Spellman S, Lee SJ, Uhrberg M, Venstrom JM, Verneris MR Biol Blood Marrow Transplant 23(1):153-160
2017 HRQoL among older related HSC donors (>60 yrs.) is equivalent to that of younger related donors (18-60 yrs.): An RDSafe study. Switzer GE, Bruce J, Kiefer DM, Kobusingye H, Drexler R, Besser RM, Confer DL, Horowitz MM, King RL, Shaw BE, Riches ML, Hayes-Lattin B, Linenberger M, Bolwell BJ, Rowley SD, Litzow MR, Pulsipher MA Biol Blood Marrow Transplant 23(1):165-171
2017 Novel HLA-DP region susceptibility loci associated with severe acute GvHD. Goyal RK, Lee SJ, Wang T, Trucco M, Haagenson M, Spellman SR, Veneris M, Ferrell RE Bone Marrow Transplant 52(1):95-100
2017 Pre-transplant exercise and hematopoietic cell transplant Survival: a secondary analysis of Blood and Marrow Transplant Clinical Trials Network (BMT CTN 0902). Wingard J, Wood WA, Martens M, Le-Rademacher J, Logan B, Knight J, Jacobsen PB, Jim H, Majhail NS, Syrjala K, Rizzo JD, Lee S Biol Blood Marrow Transplant 23(1):161-164
 
 
​​​​​

View current and planned studies
Last Updated: 3/23/2016 9:32 AM